Set to conquer US, Indian 'Viagras' may give Pfizer a hard time

The end of Pfizer's patent will open floodgates of the lucrative US market to Indian companies.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2LW8B7D
via IFTTT